Ads by Google

Multiple Sclerosis

Progressive Multiple Sclerosis Responds to Biotin

2015-04-19 10:19
progressive multiple sclerosis responds to biotin

High doses of biotin, which is also known as vitamin H, were associated with improvements in disability among patients with progressive multiple sclerosis. The results of this latest study, which follows on the heels of another research endeavor concerning biotin for multiple sclerosis, will be presented at the American Academy of Neurology annual meeting on April 24, 2015.

The phase III placebo-controlled trial involved 154 patients with progressive multiple sclerosis who were given either 300 mg per day of biotin (as the drug MD1003) or placebo for 48 weeks.

conditions: 
Latest News: 

Mesenchymal Stem Cell Therapy Trial for Multiple Sclerosis

2015-04-16 14:41
mesenchymal stem cell therapy for multiple sclerosis

The first Canadian clinical trial to explore mesenchymal stem cell therapy for multiple sclerosis is now underway with the help of a $4.2 million grant. This groundbreaking effort is under the direction of Mark S. Freedman, MD, of the University of Ottawa and The Ottawa Hospital.

Mesenchymal stem cell therapy is one of two types of stem cell therapy that has been under investigation for treatment of multiple sclerosis.

Latest News: 
conditions: 

Should You Take Fish Oil for Multiple Sclerosis?

2015-04-13 12:08
fish oil for multiple sclerosis

Considerable research revolves around the use of fish oil for a number of health challenges. What have researchers discovered about taking fish oil for multiple sclerosis?

Fish oil is a rich source of two important omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

conditions: 
Latest News: 

Fighting Fatigue in Multiple Sclerosis

2015-04-06 15:12
fighting fatigue in multiple sclerosis

Fatigue in multiple sclerosis is one of the most life-altering symptoms of the disease. Now the findings of a new study indicate that it is possible to prevent and treat fatigue by targeting certain risk factors.

According to the National Multiple Sclerosis Society, fatigue is a problem in about 80 percent of people with multiple sclerosis.

conditions: 
Latest News: 

Statins for Multiple Sclerosis

2015-03-30 17:59
statins for multiple sclerosis

A new meta-analysis and review of statins for multiple sclerosis has just been published, and it seemed like a good opportunity to take a look at what scientists say about statins for MS. It also would be enlightening to hear from people with multiple sclerosis concerning their experiences and opinions about using these drugs.

Statins (e.g., atorvastatin, lovastatin, pravastatin, rosuvastatin, simvastatin) are approved by the Food and Drug Administration (FDA) for lowering cholesterol levels.

conditions: 
Latest News: 

Curcumin and Multiple Sclerosis

2015-03-23 07:59
curcumin and multiple sclerosis

About five years ago I interviewed a young woman (let’s call her Rose) with multiple sclerosis who was managing the disease with natural remedies. One of those remedies was curcumin, a compound present in the curry spice called turmeric.

Back then, there was little in the way of scientific evidence to support the use of curcumin for treatment of multiple sclerosis.

conditions: 
Latest News: 

Blood Pressure Drug Saves Myelin in Multiple Sclerosis

2015-03-15 09:53
blood pressure drug saves myelin in multiple sclerosis

A new study showed that a drug used to treat high blood pressure prevented the loss of myelin in multiple sclerosis animal models. The blood pressure drug, called guanabenz (Wytensin), also reduced clinical symptoms of the disease.

Guanabenz is an alpha-2 adrenergic agonist that works by controlling how nerve signals move along certain pathways.

conditions: 
Latest News: 

Overactive Bladder Drug May Restore Myelin in Multiple Sclerosis

2015-03-10 10:32
restore myelin in multiple sclerosis

It appears that a drug currently on the market to treat overactive bladder may help restore myelin in patients with multiple sclerosis. More specifically, the drug promotes remyelination, a natural process that fails to progress properly in people who have MS.

Damage to the protective covering (myelin) surrounding the nerves is called demyelination.

conditions: 
Latest News: 

Multiple Sclerosis Patients Want Full Disclosure

2015-03-05 10:57
multiple sclerosis patients want full disclosure

Individuals with multiple sclerosis want to know what’s going on behind closed doors concerning drug research for this disease. A new study shows that MS patients want full disclosure concerning the financial relationship between the doctors and the drug companies in pharmaceutical industry-sponsored clinical trials (ISCTs) before they will agree to participate in such research.

Andrew Solomon, MD, a neurologist and MS specialist at the University of Vermont, and his colleagues from several other universities and medical centers, recently reported their findings in the Mul

conditions: 
Latest News: 

Role of Coffee in Multiple Sclerosis

2015-03-04 09:03
role of coffee in multiple sclerosis

The role of coffee in multiple sclerosis can be viewed from two perspectives: its ability to prevent or decrease risk of the disease and its impact on individuals who already have MS. Since a new study has addressed the former scenario, it seems like a good time to look at the effect of coffee on both sides of the question.

Coffee and MS prevention

conditions: 
Latest News: 

Pages